51 related articles for article (PubMed ID: 23884781)
1. Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies.
Vitale G; Lupoli G; Guarrasi R; Colao A; Dicitore A; Gaudenzi G; Misso G; Castellano M; Addeo R; Facchini G; Del Prete S; Caraglia M
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1567-74. PubMed ID: 23884781
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-rich gastric carcinoma in the integrated cancer registry of eastern Sicily, Italy.
Ieni A; Branca G; Parisi A; Fedele F; Irato E; Venuti A; Caruso RA
Anticancer Res; 2015 Jan; 35(1):487-92. PubMed ID: 25550592
[TBL] [Abstract][Full Text] [Related]
3. Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway.
Shao Y; Lo CM; Ling CC; Liu XB; Ng KT; Chu AC; Ma YY; Li CX; Fan ST; Man K
Cancer Lett; 2014 Dec; 355(2):264-72. PubMed ID: 25301451
[TBL] [Abstract][Full Text] [Related]
4. PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer.
Li H; Zeng J; Shen K
Arch Gynecol Obstet; 2014 Dec; 290(6):1067-78. PubMed ID: 25086744
[TBL] [Abstract][Full Text] [Related]
5. Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.
Shimabukuro-Vornhagen A; Schlößer HA; Gryschok L; Malcher J; Wennhold K; Garcia-Marquez M; Herbold T; Neuhaus LS; Becker HJ; Fiedler A; Scherwitz P; Koslowsky T; Hake R; Stippel DL; Hölscher AH; Eidt S; Hallek M; Theurich S; von Bergwelt-Baildon MS
Oncotarget; 2014 Jul; 5(13):4651-64. PubMed ID: 25026291
[TBL] [Abstract][Full Text] [Related]
6. Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer.
Iglesia MD; Vincent BG; Parker JS; Hoadley KA; Carey LA; Perou CM; Serody JS
Clin Cancer Res; 2014 Jul; 20(14):3818-29. PubMed ID: 24916698
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.
Jie HB; Gildener-Leapman N; Li J; Srivastava RM; Gibson SP; Whiteside TL; Ferris RL
Br J Cancer; 2013 Nov; 109(10):2629-35. PubMed ID: 24169351
[TBL] [Abstract][Full Text] [Related]
8. Effects of gastric cancer cells on the differentiation of Treg cells.
Hu JL; Yang Z; Tang JR; Fu XQ; Yao LJ
Asian Pac J Cancer Prev; 2013; 14(8):4607-10. PubMed ID: 24083711
[TBL] [Abstract][Full Text] [Related]
9. Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer.
Koizumi M; Hiasa Y; Kumagi T; Yamanishi H; Azemoto N; Kobata T; Matsuura B; Abe M; Onji M
PLoS One; 2013; 8(8):e71367. PubMed ID: 23940742
[TBL] [Abstract][Full Text] [Related]
10. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
Naito Y; Saito K; Shiiba K; Ohuchi A; Saigenji K; Nagura H; Ohtani H
Cancer Res; 1998 Aug; 58(16):3491-4. PubMed ID: 9721846
[TBL] [Abstract][Full Text] [Related]
11. Serum interleukin-6 levels reflect disease status of gastric cancer.
Wu CW; Wang SR; Chao MF; Wu TC; Lui WY; P'eng FK; Chi CW
Am J Gastroenterol; 1996 Jul; 91(7):1417-22. PubMed ID: 8678006
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion.
Dadmarz R; Sgagias MK; Rosenberg SA; Schwartzentruber DJ
Cancer Immunol Immunother; 1995 Jan; 40(1):1-9. PubMed ID: 7828162
[TBL] [Abstract][Full Text] [Related]
13. Radiation studies on B cell differentiation marker CD24/SCLC Cluster-4 antigen expressing and non-expressing lung cancer cell lines and mouse fibroblasts.
Weber E; Schmitter D; Resch H; Zarn JA; Waibel R; Mabry M; Huguenin P; Stahel RA
Int J Radiat Biol; 1995 Aug; 68(2):205-13. PubMed ID: 7658146
[TBL] [Abstract][Full Text] [Related]
14. T-cell markers in tumor-infiltrating lymphocytes of head and neck cancer.
Snyderman CH; Heo DS; Chen K; Whiteside TL; Johnson JT
Head Neck; 1989; 11(4):331-6. PubMed ID: 2502505
[TBL] [Abstract][Full Text] [Related]
15. Personalized Medicine in Medullary Thyroid Carcinoma: A Broad Review of Emerging Treatments.
Martins RS; Jesus TT; Cardoso L; Soares P; Vinagre J
J Pers Med; 2023 Jul; 13(7):. PubMed ID: 37511745
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of low-dose interleukin-2 therapy on chronic autoimmune thyroid disease with concurrent systemic lupus erythematosus.
Wang N; Jin Y; Cheng G; Zhang K; Huang B; Li Y; He J
Ann Med; 2023; 55(2):2238600. PubMed ID: 37489616
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into the activation of somatostatin receptor 2 by cyclic SST analogues.
Bo Q; Yang F; Li Y; Meng X; Zhang H; Zhou Y; Ling S; Sun D; Lv P; Liu L; Shi P; Tian C
Cell Discov; 2022 May; 8(1):47. PubMed ID: 35595746
[TBL] [Abstract][Full Text] [Related]
18. Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus.
Sciammarella C; Luce A; Riccardi F; Mocerino C; Modica R; Berretta M; Misso G; Cossu AM; Colao A; Vitale G; Necas A; Fedacko J; Galdiero M; Correale P; Faggiano A; Caraglia M; Capasso A; Grimaldi A
Front Oncol; 2020; 10():1047. PubMed ID: 32766136
[TBL] [Abstract][Full Text] [Related]
19. Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice.
Xi C; Zhang GQ; Sun ZK; Song HJ; Shen CT; Chen XY; Sun JW; Qiu ZL; Luo QY
Front Immunol; 2020; 11():1124. PubMed ID: 32655554
[TBL] [Abstract][Full Text] [Related]
20. Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse.
Nardone V; Botta C; Caraglia M; Martino EC; Ambrosio MR; Carfagno T; Tini P; Semeraro L; Misso G; Grimaldi A; Boccellino M; Facchini G; Berretta M; Vischi G; Rocca BJ; Barone A; Tassone P; Tagliaferri P; Del Vecchio MT; Pirtoli L; Correale P
Cancer Biol Ther; 2016 Nov; 17(11):1213-1220. PubMed ID: 27791459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
